MIHDF yields 6.41% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, MIHDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MIHDF + PFE for your $10,000?
MISC Berhad provides energy-related maritime solutions and services worldwide. The company operates through LNG (liquefied natural gas) Asset Solutions, Petroleum & Product Shipping, Offshore Business, Marine & Heavy Engineering, and Others segments. It owns and operates LNG carriers; petroleum and chemical tankers; and floating storage and offloading, and mobile offshore production units; and semi-submersible floating production systems. The company is also involved in the provision of marine and heavy engineering services, including engineering, procurement, construction, installation, and commissioning services for offshore and onshore construction; and marine repair and conversion works. In addition, it offers maritime education and training services for seamen and maritime personnel; port and terminal services; marine transportation; integrated marine services; and crew management and dry docking of marine vessels services. Further, the company operates and manages the Sungai Udang Port; and owns properties. As of February 17, 2022, it operated a fleet of approximately 100 owned and in-chartered comprising of LNG, petroleum, and product vessels; floating production systems; and LNG floating storage units with a combined deadweight tonnage capacity of approximately 13 million tonnes. The company was incorporated in 1968 and is headquartered in Kuala Lumpur, Malaysia. MISC Berhad operates as a subsidiary of Petroliam Nasional Berhad.
Full MIHDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.